J&J Settlement Leaves Teva As Sole Opioid Maker In Bellwether Trial

Four distributors and Walgreens also remain defendants; court to consider Teva's motion to dismiss if the trial results in a judgement against its subsidiaries. Seven-week trial could include 215 witnesses and 21,000 exhibits.

Ohio map
J&J is fourth opioid manufacturer to settle out of the bellwether trial in Ohio

More from Legal & IP

More from Pink Sheet